Home - National Multiple Sclerosis Society

Skip to navigation Skip to content
National MS Society

Email not displaying correctly? View it in your browser.
Dec_eNEWS_feature_image.jpg

On December 13, 2011, join moderator Dr. Timothy Coetzee, the Society’s chief research officer, and a panel of experts for a live nationwide webcast, “From the Frontlines: What’s New in MS Research for 2012." Topics include vitamin D, CCSVI, emerging therapies and more.

Register now  

 

 Find us on Facebook 

YouTube MySpace Twitter


Social worker and MS activist Jackie Jackson
 

Become or support an MS Scholar
 

Opexa Therapeutics announced that the FDA designated their experimental vaccine Tovaxin as a “Fast Track Product” for the treatment of secondary-progressive MS. The company is planning to begin a Phase IIb clinical trial “subject to securing the necessary resources,” according to a recent press release.

Get the full story

 

 

Bring us closer to a world free of MS in 2012! Your donation will accelerate promising new reseach leads, fund life-changing programs and provide financial assistance for people with MS. Thank you for everything you do to help us keep moving toward a world free of MS. Please make your year-end, tax-deductible gift today!

More MS News 

Dec 7: New clues to early disease activity may offer new avenues for stopping MS

Nov 28: Researchers recruiting African-Americans with MS and family members across the U.S. for genetics studies

Nov 15: Positive results announced from second phase III study of alemtuzumab in MS

Read more about these and other recent reports

This communication is partially sponsored through the generous support of Biogen Idec;
EMD Serono and Pfizer, Inc; Novartis Pharmaceuticals Corporation; and Teva Neuroscience, Inc.
 

MS Active Source  MS LifeLinesNovartis Teva Neuroscience

Join a Walk MS Event       Join a Bike MS Event      Shop at the Society Store

National MS Society | View as Web page | Subscribe | Legal Notice/Privacy Policy | Email Preferences | Unsubscribe

MS stops people from moving. The National MS Society exists to make sure it doesn’t. We are a collective of passionate individuals, moving together to create a world free of MS.
JOIN THE MOVEMENT®

Please do not reply to this email as we are unable to quickly respond to messages sent to this address. To receive information about living with MS, Bike MS or Walk MS — or to contact National MS Society staff in your area — please
visit our website.

Early and ongoing treatment with an FDA-approved therapy can make a difference for people with multiple sclerosis. Learn about your options by talking to your health care professional and contacting the National MS Society at http://www.nationalmssociety.org/ or 1-800-344-4867.

National Multiple Sclerosis Society | 733 Third Avenue | New York, NY | 10017

This message was sent to  .
To ensure that you continue to receive our emails, please add us to your address book.



Early and ongoing treatment with an FDA-approved therapy can make a difference for people with multiple sclerosis. Learn about your options by talking to your health care professional and contacting the National MS Society at http://main.nationalmssociety.org/ or 1-800-FIGHT-MS (344-4867).

Our postal address is:
National Multiple Sclerosis Society
733 Third Avenue
New York, New York 10017

Unsubscribe
Email Preferences
Forward to a Friend
Privacy Policy

Powered By Blackbaud